Yen Y. Wang

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2018 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Priyanka Sharma, Vandana G. Abramson, Anne O’Dea et al. · Clinical Cancer Research · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Rachel Yoder, Bruce F. Kimler, Joshua M. Staley et al. · npj Breast Cancer · 2022 · 74 citations · Full text

Medicine, Oncology, Breast Oncology +13

In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells

Kim Anthony-Gonda, Alex Ray, Hang Su et al. · JCI Insight · 2022 · 47 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17